Structures by: Sánchez A.
Total: 168
Aquacadmium(II)-(-(3,4-toluenediamine-N,N,N',N'-tetraacetato)-cadmium(II)aqua
C15H14N2O8Cd2,2H2O
Journal of the Chemical Society, Dalton Transactions (2001) 10 1559
a=8.597(2)Å b=24.346(2)Å c=9.197(2)Å
α=90.00° β=106.10(3)° γ=90.00°
C28H34Hg1.5NO3S
C28H34Hg1.5NO3S
New J. Chem. (2016) 40, 8 6735
a=10.9653(8)Å b=24.1931(17)Å c=10.7357(7)Å
α=90.00° β=93.070(2)° γ=90.00°
C22H29HgNO3S
C22H29HgNO3S
New J. Chem. (2016) 40, 8 6735
a=9.977(3)Å b=10.614(3)Å c=12.809(3)Å
α=111.613(4)° β=95.651(4)° γ=109.288(4)°
C22H29HgNO3S
C22H29HgNO3S
New J. Chem. (2016) 40, 8 6735
a=10.1999(8)Å b=11.0816(8)Å c=12.1792(10)Å
α=101.7130(10)° β=103.418(2)° γ=113.8760(10)°
C44H52F6Hg2N2O6S2
C44H52F6Hg2N2O6S2
New J. Chem. (2016) 40, 8 6735
a=10.9515(9)Å b=15.1588(12)Å c=16.0378(13)Å
α=91.515(2)° β=109.962(2)° γ=92.162(2)°
(2-forylimidazole thiosemicarbazonato)dimethyltin(IV) ethanol solvate
C9H17N5OSSn
Journal of the Chemical Society, Dalton Transactions (2000) 14 2267
a=22.920(8)Å b=6.3651(7)Å c=10.488(4)Å
α=90.00° β=101.655(16)° γ=90.00°
2-forylimidazole thiosemicarbazone
C5H8N5O0.5S
Journal of the Chemical Society, Dalton Transactions (2000) 14 2267
a=7.7676(9)Å b=7.8401(9)Å c=15.873(2)Å
α=81.828(9)° β=89.140(10)° γ=61.146(9)°
C30H44Ag2N2O4S2
C30H44Ag2N2O4S2
Dalton transactions (Cambridge, England : 2003) (2007) 28 3074-3085
a=11.658(3)Å b=14.597(4)Å c=19.874(5)Å
α=91.661(5)° β=97.236(4)° γ=100.182(4)°
C52H96Ag4N4O8S4
C52H96Ag4N4O8S4
Dalton transactions (Cambridge, England : 2003) (2007) 28 3074-3085
a=13.115(5)Å b=17.310(5)Å c=27.739(5)Å
α=90.000(5)° β=99.078(5)° γ=90.000(5)°
C27H22AgO2PS
C27H22AgO2PS
Dalton transactions (Cambridge, England : 2003) (2005) 9 1707-1715
a=14.056(4)Å b=9.356(3)Å c=19.162(5)Å
α=90.00° β=109.806(6)° γ=90.00°
C46H38Ag2O3P2S
C46H38Ag2O3P2S
Dalton transactions (Cambridge, England : 2003) (2005) 9 1707-1715
a=13.4962(9)Å b=17.1129(11)Å c=18.6400(11)Å
α=90.00° β=107.1740(10)° γ=90.00°
C45H35Ag2ClO2P2S
C45H35Ag2ClO2P2S
Dalton transactions (Cambridge, England : 2003) (2005) 9 1707-1715
a=11.7866(10)Å b=13.2797(12)Å c=14.8441(13)Å
α=113.369(2)° β=104.383(2)° γ=96.518(2)°
C48H43Ag2O4P2S
C48H43Ag2O4P2S
Dalton transactions (Cambridge, England : 2003) (2005) 9 1707-1715
a=12.6832(13)Å b=13.5698(14)Å c=15.7147(17)Å
α=107.707(2)° β=98.165(2)° γ=113.460(2)°
C46H40Ag2O4P2S
C46H40Ag2O4P2S
Dalton transactions (Cambridge, England : 2003) (2005) 9 1707-1715
a=17.5325(12)Å b=13.1244(9)Å c=18.6677(12)Å
α=90.00° β=100.0680(10)° γ=90.00°
C45H34Ag2Br2O3P2S
C45H34Ag2Br2O3P2S
Dalton transactions (Cambridge, England : 2003) (2005) 9 1707-1715
a=15.7725(9)Å b=17.2472(10)Å c=17.4361(9)Å
α=90.00° β=116.0150(10)° γ=90.00°
C61H50AgO3P3S
C61H50AgO3P3S
Dalton transactions (Cambridge, England : 2003) (2005) 9 1707-1715
a=12.2174(16)Å b=20.525(3)Å c=20.943(3)Å
α=90.00° β=95.790(3)° γ=90.00°
Bis(3-(2-thienyl)-propenoic)-2,2'-disulfide acetone solvate
C17H16O5S4
Dalton Trans. (2003) 24 4754-4761
a=7.3669(7)Å b=17.7955(17)Å c=14.8798(15)Å
α=90.00° β=96.630(2)° γ=90.00°
Mu-3-(2-furyl)-2-sulfanylpropenoate-kappaS)- triphenylphosphine-kappaP-gold(i)
C25H20AuO3PS
Dalton Trans. (2003) 24 4754-4761
a=11.2143(16)Å b=27.397(4)Å c=15.353(2)Å
α=90.00° β=91.373(3)° γ=90.00°
Diisopropylammonium (mu-3-(3-phenyl)-2-sulfanylatepropenoate- kappaS-triphenylphosphine-kappaP-aurate(-1)
C33H37AuNO2PS
Dalton Trans. (2003) 24 4754-4761
a=9.8237(12)Å b=13.9493(17)Å c=23.244(3)Å
α=90.00° β=101.027(3)° γ=90.00°
Mu-3-(2-furyl)-2-sulfanylpropenoate-1:2kappaS:2kappaO'- bis(triphenylphosphine-1kappaP,2kappaP)-digold
C45H42Au2O4P2S2
Dalton Trans. (2003) 24 4754-4761
a=21.106(3)Å b=13.354(2)Å c=16.268(2)Å
α=90.00° β=111.560(3)° γ=90.00°
Mu-3-(2-furyl)-2-sulfanylpropenoate-1:2kappaS:2kappaO'- bis(triphenylphosphine-1kappaP,2kappaP)-digold
C43H34Au2O3P2S
Dalton Trans. (2003) 24 4754-4761
a=9.8209(8)Å b=17.8496(15)Å c=22.7002(19)Å
α=90.00° β=92.495(2)° γ=90.00°
Mu-3-(2-furyl)-2-sulfanylpropenoate-1:2kappaS:2kappaO'- bis(triphenylphosphine-1kappaP,2kappaP)-digold
C47H44Au2O4P2S
Dalton Trans. (2003) 24 4754-4761
a=21.6565(12)Å b=13.3177(7)Å c=16.1683(9)Å
α=90.00° β=110.8850(10)° γ=90.00°
3-isatin thiosemicarbazone
C9H8N4OS
Journal of the Chemical Society, Dalton Transactions (2000) 22 4056
a=15.0072(18)Å b=15.2500(19)Å c=4.3768(5)Å
α=90.00° β=90.00° γ=90.00°
Dimethylbis(diphenyldithiophosphinato)tin(IV)
C26H26P2S4Sn
Journal of the Chemical Society, Dalton Transactions (2000) 22 4056
a=10.6068(16)Å b=11.2736(9)Å c=13.7638(10)Å
α=112.017(7)° β=99.495(10)° γ=104.361(9)°
(3-isatinethiosemicarbazonato)-dimethyl-monothiophosphinato-tin(IV) ethanol solvate
C25H29N4O3PS2Sn
Journal of the Chemical Society, Dalton Transactions (2000) 22 4056
a=10.558(2)Å b=10.958(2)Å c=13.978(3)Å
α=88.723(10)° β=77.833(10)° γ=62.28(2)°
(2,3-isatin-bis(thiosemicarbazonato))-dimethyltin(IV)
C12H15N7S2Sn
Journal of the Chemical Society, Dalton Transactions (2000) 22 4056
a=14.913(3)Å b=7.3408(14)Å c=15.188(3)Å
α=90.00° β=102.933(10)° γ=90.00°
[Zn(L4)2]0.5(H2O)
[Zn(C6H8N3O2S)2]0.5(H2O)
Dalton transactions (Cambridge, England : 2003) (2004) 13 2019-2026
a=9.3579(15)Å b=9.3579(15)Å c=22.554(5)Å
α=90.00° β=90.00° γ=90.00°
[Cd(L5)2(dmso)]dmso
[Cd(C10H8N3OS)2(CH3)2SO](CH3)2SO
Dalton transactions (Cambridge, England : 2003) (2004) 13 2019-2026
a=10.636(3)Å b=13.317(3)Å c=20.713(5)Å
α=90.00° β=91.174(5)° γ=90.00°
HL5
C10H9N3OS
Dalton transactions (Cambridge, England : 2003) (2004) 13 2019-2026
a=6.0107(3)Å b=7.8604(13)Å c=11.2049(9)Å
α=94.399(12)° β=100.733(7)° γ=95.417(11)°
HL3
C6H9N3OS
Dalton transactions (Cambridge, England : 2003) (2004) 13 2019-2026
a=18.825(4)Å b=6.9385(14)Å c=6.1461(12)Å
α=90.00° β=90.087(3)° γ=90.00°
E2cd
[Cd(C6H8N3OS)2(H2O)].2[[CH3)2SO]
Dalton transactions (Cambridge, England : 2003) (2004) 13 2019-2026
a=15.665(3)Å b=20.270(4)Å c=8.1761(17)Å
α=90.00° β=100.030(3)° γ=90.00°
C96H144Ag6N6O18S6
C96H144Ag6N6O18S6
Dalton transactions (Cambridge, England : 2003) (2013) 42, 16 5916-5923
a=15.313(2)Å b=15.313(2)Å c=43.690(10)Å
α=90.00° β=90.00° γ=120.00°
C9H8O2S
C9H8O2S
Dalton transactions (Cambridge, England : 2003) (2010) 39, 16 3931-3943
a=6.3072(10)Å b=16.4712(10)Å c=8.717(2)Å
α=90.00° β=102.303(10)° γ=90.00°
C30H44N2O4S2Zn
C30H44N2O4S2Zn
Dalton transactions (Cambridge, England : 2003) (2010) 39, 16 3931-3943
a=14.9443(10)Å b=15.826(3)Å c=27.464(3)Å
α=90.00° β=90.00° γ=90.00°
C30H42Cl2N2O4S2Zn
C30H42Cl2N2O4S2Zn
Dalton transactions (Cambridge, England : 2003) (2010) 39, 16 3931-3943
a=14.415(2)Å b=7.7905(11)Å c=17.9381(18)Å
α=90.00° β=120.395(8)° γ=90.00°
C26H40N2O4S4Zn
C26H40N2O4S4Zn
Dalton transactions (Cambridge, England : 2003) (2010) 39, 16 3931-3943
a=14.0680(10)Å b=15.065(2)Å c=16.045(3)Å
α=90.00° β=112.822(10)° γ=90.00°
C26H40N2O6S2Zn
C26H40N2O6S2Zn
Dalton transactions (Cambridge, England : 2003) (2010) 39, 16 3931-3943
a=9.0837(11)Å b=12.8696(15)Å c=14.8088(17)Å
α=69.626(2)° β=75.541(2)° γ=81.680(2)°
C30H44CdN2O4S2
C30H44CdN2O4S2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 16 3931-3943
a=13.901(2)Å b=9.9576(17)Å c=25.286(2)Å
α=90.00° β=96.500(10)° γ=90.00°
C30H42CdCl2N2O4S2
C30H42CdCl2N2O4S2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 16 3931-3943
a=13.482(3)Å b=14.585(3)Å c=17.589(4)Å
α=90.00° β=95.630(4)° γ=90.00°
C12H15NO2SSn
C12H15NO2SSn
Journal of the Chemical Society, Dalton Transactions (1998) 9 1513
a=23.455(4)Å b=11.1793(14)Å c=10.3097(12)Å
α=90.00° β=90.00° γ=90.00°
C16H21ClNORu,F6Sb,CH2Cl2
C16H21ClNORu,F6Sb,CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 41 15546-15559
a=11.0410(10)Å b=11.4271(11)Å c=12.2760(10)Å
α=62.5660(10)° β=64.0080(10)° γ=61.4100(10)°
C17H24ClIrNO,SbF6
C17H24ClIrNO,SbF6
Dalton transactions (Cambridge, England : 2003) (2014) 43, 41 15546-15559
a=8.0156(4)Å b=12.8917(7)Å c=20.3840(10)Å
α=90.000(5)° β=90.000(5)° γ=90.000(5)°
C38H39N2O3PRh,2(F6Sb)
C38H39N2O3PRh,2(F6Sb)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 41 15546-15559
a=32.966(2)Å b=12.6937(8)Å c=23.6444(15)Å
α=90.000(5)° β=124.2590(10)° γ=90.000(5)°
C39H41N2O3PRu,2(F6Sb),CH2Cl2
C39H41N2O3PRu,2(F6Sb),CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 41 15546-15559
a=12.4981(13)Å b=18.5920(19)Å c=20.181(2)Å
α=90.00° β=90.00° γ=90.00°
C32H33Cl2IrNO2P,0.5(CH2Cl2)
C32H33Cl2IrNO2P,0.5(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 41 15546-15559
a=17.7988(7)Å b=22.9780(10)Å c=7.6967(3)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-4-benzylamino-6-benzyloxy-5-nitrosopyrimidine
C18H17N5O2
Acta Crystallographica Section B (2002) 58, 2 300-315
a=11.677(2)Å b=13.362(3)Å c=21.478(4)Å
α=90.00° β=102.58(3)° γ=90.00°
Ethyl N-(2-amino-6-benzyloxypyrimidin-4-yl)gylcinate
C15H17N5O4
Acta Crystallographica Section B (2002) 58, 2 300-315
a=7.3525(4)Å b=7.5420(5)Å c=14.9454(13)Å
α=91.797(3)° β=100.467(3)° γ=106.102(6)°
Ethyl N-(2-amino-6 benzyloxy-5-nitrosopyrimidin-4-yl)-β-alaninate
C16H19N5O4
Acta Crystallographica Section B (2002) 58, 2 300-315
a=5.2399(16)Å b=31.1630(14)Å c=9.792(4)Å
α=90.00° β=100.200(12)° γ=90.00°
Ethyl N-(2-amino-6-benzyloxo-5-nitrosopyrimidin-4-yl)-β-alaninate
C16H19N5O4
Acta Crystallographica Section B (2002) 58, 2 300-315
a=7.4830(2)Å b=16.6110(6)Å c=13.5378(6)Å
α=90.00° β=91.5420(11)° γ=90.00°
Ethyl N-(2-amino-6-benzyloxy-5-nitrosopyrimidin-4-yl)-L-phenylalaninate
C22H23N5O4
Acta Crystallographica Section B (2002) 58, 2 300-315
a=7.9899(3)Å b=8.4278(3)Å c=17.0042(7)Å
α=99.9100(12)° β=90.5610(13)° γ=111.4880(17)°
Ethyl N-(2-benzylamino-6-benzyloxy-5-nitrosopyrimidin-4-yl)-β-alaninate
C23H25N5O4
Acta Crystallographica Section B (2002) 58, 2 300-315
a=8.6595(2)Å b=16.3567(4)Å c=16.9014(4)Å
α=105.2210(13)° β=104.6960(13)° γ=100.3720(12)°
4-Benzylamino-2, 6-bis(benzyloxy)-5-nitrosopyrimidine
C25H22N4O3
Acta Crystallographica Section B (2002) 58, 2 300-315
a=14.6856(5)Å b=7.7726(2)Å c=18.5721(8)Å
α=90.00° β=99.8847(13)° γ=90.00°
2-Benzylamino-4,6-bis(benzyloxy)-5-nitrosopyrimidine
C25H22N4O3
Acta Crystallographica Section B (2002) 58, 2 300-315
a=13.8074(3)Å b=15.8175(5)Å c=10.2119(5)Å
α=90.00° β=105.7490(11)° γ=90.00°
2-Amino-4,6-bis(benzyloxy)pyrimidine
C18H17N3O2
Acta Crystallographica Section B (2002) 58, 2 300-315
a=32.4902(9)Å b=7.5034(2)Å c=12.7804(4)Å
α=90.00° β=98.8790(16)° γ=90.00°
2-Amino-4,6-bis(pyrrolidino)-5-nitrosopyrimidine hydrate
C12H19.1N6O1.55
Acta Crystallographica Section B (2002) 58, 2 300-315
a=18.4687(8)Å b=8.1067(3)Å c=19.1880(6)Å
α=90.00° β=110.580(2)° γ=90.00°
2,5-dihydro-3,4-dimethyl-5-oxo-1H-pyrazole-1-carbothioamide
C6H9N3OS
Acta Crystallographica Section E (2002) 58, 7 o787-o789
a=7.9246(13)Å b=12.543(2)Å c=16.015(3)Å
α=90.00° β=90.00° γ=90.00°
2-(Benzotriazol-1-ylmethyl)-1-phenyl-3-pyrazolidinone
C16H15N5O
Acta Crystallographica Section E (2003) 59, 1 o66-o69
a=6.4009(2)Å b=8.3596(3)Å c=13.2794(5)Å
α=92.7780(10)° β=94.3820(10)° γ=95.039(3)°
3-tert-butyl-5-[(4-methoxybenzylidene)amino]-1-phenylpyrazole
C21H23N3O
Acta Crystallographica Section E (2003) 59, 2 o250-o252
a=10.0744(3)Å b=6.2583(2)Å c=28.9244(9)Å
α=90.00° β=101.0410(13)° γ=90.00°
1-(4-bromophenyl)-3-[2-(2-hydroxyethyl)amino-5-nitroanilino]-1-propanone
C17H18BrN3O4,C3H7NO
Acta Crystallographica Section E (2003) 59, 3 o296-o298
a=10.5267(2)Å b=10.7688(3)Å c=10.9397(3)Å
α=77.646(2)° β=72.743(2)° γ=62.7565(12)°
6(R)-Acetoxymethyl-5(S)-acetyl-2(S)-(benzotriazol-1-yl)-5,6-dihydro-2H-pyran
C16H17N3O5
Acta Crystallographica Section E (2003) 59, 3 o334-o336
a=5.5167(3)Å b=17.7388(11)Å c=8.2217(5)Å
α=90.00° β=94.139(3)° γ=90.00°
5-(Benzo[1,3]dioxol-5-yl)-7-(4-chloro-phenyl)-3-methyl-1-phenyl-1,6,7,8- tetrahydropyrazolo[3,4-b][1,4]diazepine
C26H21ClN4O2
Acta Crystallographica Section E (2003) 59, 1 o18-o20
a=11.3422(2)Å b=15.6889(3)Å c=24.1716(5)Å
α=90.00° β=92.4370(10)° γ=90.00°
4-(4-bromophenyl)-3,7,7-trimethyl-4,7,8,9-tetrahydro-2H-pyrazolo[3,4-b] quinolin-5(6H)-one
C19H20BrN3O
Acta Crystallographica Section E (2001) 57, 2 o151-o153
a=8.6673(2)Å b=14.6092(3)Å c=14.4783(5)Å
α=90.00° β=107.2870(10)° γ=90.00°
3,7,7-Trimethyl-4-(β-naphthyl)-4,7,8,9-tetrahydro-2H-pyrazolo[3,4-b]- quinolin-5(6H)-one
C23H23N3O
Acta Crystallographica Section E (2001) 57, 2 o160-o162
a=9.1222(18)Å b=15.281(3)Å c=14.346(3)Å
α=90.00° β=106.13(3)° γ=90.00°
5-(1,3-Benzothiazol-2-yliminomethyl)-2,2-dimethyl-1,3-dioxane-4,6-dione
C14H12N2O4S
Acta Crystallographica Section E (2001) 57, 2 o180-o181
a=6.3459(13)Å b=19.235(4)Å c=11.144(2)Å
α=90.00° β=103.07(3)° γ=90.00°
6-(2-Hydroxybenzoyl)-2-(4-nitrophenyl)pyrazolo[1,5-a]pyrimidine
C19H12N4O4
Acta Crystallographica Section E (2001) 57, 2 o182-o184
a=5.5421(2)Å b=11.5858(5)Å c=23.8057(13)Å
α=90.00° β=90.00° γ=90.00°
5,5-Dimethyl-3-[(5-phenyl-1H-pyrazol-3-yl)amino]cyclohex-2-en-1-one
C17H19N3O
Acta Crystallographica Section E (2001) 57, 2 o185-o186
a=19.0427(2)Å b=9.6024(4)Å c=16.6135(7)Å
α=90.00° β=90.00° γ=90.00°
6-(2-hydroxybenzoyl)-2-phenylpyrazolo[1,5-a]pyrimidine
C19H13N3O2
Acta Crystallographica Section E (2001) 57, 2 o187-o188
a=5.6606(2)Å b=11.7048(5)Å c=21.6815(10)Å
α=90.00° β=94.7970(15)° γ=90.00°
3,7,7-Trimethyl-4-(4-methoxyphenyl)-4,7,8,9-tetrahydro-2H-pyrazolo[3,4-b]- quinolin-5(6H)-one (4).
C20H23N3O2
Acta Crystallographica Section E (2001) 57, 2 o154-o156
a=8.5820(3)Å b=14.7031(5)Å c=14.5369(8)Å
α=90.00° β=106.0610(15)° γ=90.00°
3,7,7-Trimethyl-4-phenyl-4,7,8,9-tetrahydro-2H-pyrazolo[3,4-b]quinolin-5- (6H)-one
C19H21N3O
Acta Crystallographica Section E (2001) 57, 2 o157-o159
a=10.0870(5)Å b=14.1978(5)Å c=11.1928(8)Å
α=90.00° β=96.0340(14)° γ=90.00°
6-(1H-1,2,3-Benzotriazol-1-yl)-1,2,5,6-tetrahydro-4H-pyrrolo[3,2,1-ij]quinoline
C17H16N4
Acta Crystallographica Section E (2001) 57, 2 o178-o179
a=10.7112(3)Å b=10.8297(3)Å c=23.6321(5)Å
α=90.00° β=90.00° γ=90.00°
5-Amino-4-(benzotriazol-1-ylmethyl)-1-phenyl-3-tert-butylpyrazole
C20H22N6
Acta Crystallographica Section E (2002) 58, 1 o53-o54
a=13.465(3)Å b=15.135(3)Å c=9.1558(18)Å
α=90.00° β=108.86(3)° γ=90.00°
5-[(6-Chloro-[1,3]benzothiazol-2-ylamino)-methylene]-2,2-dimethyl- [1,3]dioxane-4,6-dione
C14H11ClN2O4S
Acta Crystallographica Section E (2002) 58, 1 o57-o58
a=5.3389(4)Å b=28.583(2)Å c=9.8618(8)Å
α=90.00° β=109.178(4)° γ=90.00°
1-(2-Methyl-2,3-dihydro-indol-1-ylmethyl)-1H-benzotriazole
C16H16N4
Acta Crystallographica Section E (2002) 58, 1 o55-o56
a=7.5660(3)Å b=17.7842(8)Å c=10.2284(4)Å
α=90.00° β=104.689(3)° γ=90.00°
3-(Benzotriazol-1-yl)-p-nitropropiophenone
C15H12N4O3
Acta Crystallographica Section E (2002) 58, 7 o769-o771
a=5.9554(2)Å b=6.9671(3)Å c=31.8248(13)Å
α=90.00° β=96.8560(17)° γ=90.00°
11-Chloro-5H-6,7-dihydrobenzothiazolo[2,3-b]benzo[h]quinazoline
C18H13Cl1N2S1
Acta Crystallographica Section E (2001) 57, 10 o937-o938
a=7.2637(3)Å b=14.4294(5)Å c=15.1081(5)Å
α=70.368(3)° β=78.550(2)° γ=89.0800(14)°
[(3R,4S,4aR,10aS)-5,10-diacetyl-3,4,4a,5,6,7,10a,10-octahydro-8-methoxy-6-oxo -2H-pyrano[3,2g]pteridin]-3,4-diyl diacetate
C18H22N4O9
Acta Crystallographica Section C (1999) 55, 3 452-454
a=7.941(3)Å b=17.481(2)Å c=14.511(3)Å
α=90.00° β=90.00° γ=90.00°
Dimethyl-2-(6-benzyloxy-2-methylthio-4-pyrimidinyl)imino-3-(triphenyl- λ^5^-phosphanylidene)succinate
C36H32N3O5PS
Acta Crystallographica Section C (1999) 55, 12 IUC9900150
a=10.4027(2)Å b=11.5682(2)Å c=14.9296(3)Å
α=77.0833(13)° β=72.0218(12)° γ=85.2316(11)°
5-Cyano-4-(4-methoxyphenyl)-3,6-diphenyl-4,7-dihydro-2H-pyrazolo- [3,4-b]pyridine
C26H20N4O
Acta Crystallographica Section C (1999) 55, 12 IUC9900168
a=15.6264(3)Å b=12.4397(2)Å c=21.1296(4)Å
α=90.00° β=91.4371(9)° γ=90.00°
3,4-Bis(4-chlorophenyl)-5-cyano-6-phenyl-1H-pyrazolo-[3,4-b]pyridine
C25H14Cl2N4
Acta Crystallographica Section C (1999) 55, 12 IUC9900168
a=6.6222(5)Å b=11.0791(10)Å c=28.264(2)Å
α=90.00° β=96.248(5)° γ=90.00°
6-Amino-5-N-acetyl-N-(β-D-3,4,6-tri-O-acetylglucopyranosyl)amino- 2,4-dioxo-1,2,3,4-tetrahydro-3-methylpyrimidine, water solvent
C19H26N4O11,H2O
Acta Crystallographica Section C (1999) 55, 12 IUC9900164
a=14.3951(11)Å b=8.9771(9)Å c=19.052(2)Å
α=90.00° β=90.00° γ=90.00°
2,4-Dioxo-7-(D-arabino-1,2,3,4-tetraacetyloxibutyl)-1-methyl- 1,2,3,4-tetrahydropteridine
C19H22N4O10
Acta Crystallographica Section C (1999) 55, 12 IUC9900163
a=7.7633(8)Å b=22.049(2)Å c=13.0223(19)Å
α=90.00° β=90.00° γ=90.00°
6-Acetamido-5-N-acetyl-N-(β-D-2,3,4,6-tetra-O-acetylglucopyranosyl)amino- 2,4-dioxo-1,2,3,4-tetrahydro-3-methyl-pyrimidine
C23H30N4O13
Acta Crystallographica Section C (1999) 55, 12 IUC9900164
a=9.0315(8)Å b=17.0918(13)Å c=18.1487(13)Å
α=90.00° β=90.00° γ=90.00°
4-(4-chlorophenyl)-5-cyano-3-(4-methylphenyl)-6-diphenyl-4,7-dihydro-2H-pyrazolo [3,4-b]pyridine:dimethylformamide (2/1)
2C26H19ClN4,C3H7NO
Acta Crystallographica Section C (1999) 55, 12 IUC9900168
a=12.4124(5)Å b=13.8275(4)Å c=14.3744(6)Å
α=91.747(2)° β=106.6376(17)° γ=99.610(2)°
N-(6-Amino-3,4-dihydro-3-methyl-5-nitroso-4-oxopyrimidin-2-yl)glycine Dihydrate
C7H9N5O4,2H2O
Acta Crystallographica Section C (1997) 53, 7 890-892
a=9.2739(13)Å b=16.682(2)Å c=14.690(2)Å
α=90.00° β=90.00° γ=90.00°
(3R,4R,4aS,10aR)-5-acetyl-3,4,4a,5,6,7,10,10a-octahydro-8-methoxy-7-methyl-6- oxo-2H-pyrano[3,2-g]pteridin-3,4-diyl diacetate
C17H22N4O8
Acta Crystallographica Section C (1995) 51, 10 2141-2143
a=9.9075(7)Å b=12.4566(13)Å c=16.047(2)Å
α=90.0° β=90.0° γ=90.0°
2-amino-4,5-dicarbomethoxy-6-methoxypyridine
C10H12N2O5
Acta Crystallographica Section C (1996) 52, 1 143-145
a=7.2245(15)Å b=8.7974(13)Å c=9.181(2)Å
α=81.627(13)° β=80.521(13)° γ=76.580(15)°
2-(2,3,4-tri-O-acetyl-β-D-xylopyranosyl)amino-4,5-dicarbomethoxy-6-methoxy- pyridine
C21H26N2O12
Acta Crystallographica Section C (1996) 52, 1 145-148
a=7.8019(10)Å b=15.889(2)Å c=10.202(2)Å
α=90° β=96.24(2)° γ=90°
2-(2,3,4-tri-O-acetyl-β-D-xylopyranosyl)amino-4,5-dicarbomethoxy-6- methylthiopyridine
C21H26N2O11S
Acta Crystallographica Section C (1996) 52, 1 145-148
a=7.8583(9)Å b=15.842(2)Å c=10.368(2)Å
α=90° β=94.047(14)° γ=90°
5-Dimethylamino-2-methoxy-3-methyl-6-[1,2-(Z)-dicarbomethoxyvinyl]amino pyrimidin-4-(3H)-one
C14H20N4O6
Acta Crystallographica Section C (1996) 52, 1 254-256
a=8.7777(7)Å b=16.8264(18)Å c=11.3773(9)Å
α=90.00° β=93.077(7)° γ=90.00°
2-methylthio-5-nitroso-6-N-(2,3,4-tri-O-acetyl-β-D-xylopyranosyl)amino- pyrimidin-4-(3H)-one
C16H20N4O9S1
Acta Crystallographica Section C (1996) 52, 1 148-150
a=6.9874(4)Å b=10.647(2)Å c=27.0341(16)Å
α=90.00° β=90.00° γ=90.00°
(3S,4S,4aR,10as)-5,10-Diacetyl-3,4,4a,5,6,7,10,10a-octahydro-8-methoxy-6-oxo -2H-pyrano[3,2g]pteridin-3,4-diyl diacetate
C17H22N4O8
Acta Crystallographica Section C (1998) 54, 11 IUC9800060
a=9.9115(13)Å b=12.4531(13)Å c=16.053(3)Å
α=90.00° β=90.00° γ=90.00°
5,5,6-Triacetyl-5,6-diaminopyrimidine-2,4-(1H,3H)-dione
C10H12N4O5
Acta Crystallographica Section C (1999) 55, 5 749-751
a=22.2132(15)Å b=12.9986(13)Å c=8.5456(5)Å
α=90.00° β=96.107(5)° γ=90.00°
6-(1H-indol-3-yl)-3-methyl-4-(4-methylphenyl)-1-phenyl-1H- pyrazolo[3,4-b]pyridine-5-carbonitrile
C29H21N5,C3H7NO
Acta Crystallographica Section C (2007) 63, 5 o287-o291
a=9.8060(3)Å b=10.1820(3)Å c=13.818(2)Å
α=97.035(6)° β=104.455(6)° γ=96.171(3)°
6-(1H-indol-3-yl)-3-methyl-4-(4-methoxyphenyl)-1-phenyl-1H- pyrazolo[3,4-b]pyridine-5-carbonitrile
C29H21N5O,C3H7NO
Acta Crystallographica Section C (2007) 63, 5 o287-o291
a=30.303(3)Å b=11.3490(16)Å c=20.344(3)Å
α=90.00° β=131.010(5)° γ=90.00°
6-(1H-indol-3-yl)-3-methyl-1-phenyl-4-(3,4,5-trimethoxyphenyl)-1H- pyrazolo[3,4-b]pyridine-5-carbonitrile
C31H25N5O3
Acta Crystallographica Section C (2007) 63, 5 o287-o291
a=8.8241(10)Å b=11.9901(9)Å c=12.9130(17)Å
α=99.372(9)° β=108.822(12)° γ=90.994(7)°
Methyl 4-amino-1,3-dioxo-2,3-dihydro-6-methoxy-1H- pyrrolo[3,4-c]pyridine-7-carboxylate
C10H9N3O5
Acta Crystallographica Section C (2001) 57, 5 597-599
a=6.8189(2)Å b=16.1505(4)Å c=9.6257(3)Å
α=90° β=100.7612(13)° γ=90°
N-(2-amino-1,6-dihydro-5-nitroso-6-oxopyrimidin-4-yl)-L- isoleucine--water (4/1)
2C10H15N5O4,0.5H2O
Acta Crystallographica Section C (2001) 57, 5 604-607
a=21.4179(6)Å b=11.1466(2)Å c=14.9649(3)Å
α=90° β=133.4280(6)° γ=90°
Methyl 7-hydroxy-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropteridine-6-carboxylate-- dimethyl sulfoxide (1/1)
C11H12N4O5,C2H6OS
Acta Crystallographica Section C (2001) 57, 5 608-610
a=8.8926(2)Å b=10.2539(2)Å c=10.8500(4)Å
α=62.2233(10)° β=82.4797(10)° γ=69.1050(14)°
C17H24Cl2N4Sn
C17H24Cl2N4Sn
Acta Crystallographica Section C (2000) 56, 8 932-933
a=15.590(2)Å b=10.889(2)Å c=11.8700(10)Å
α=90° β=95.982(10)° γ=90°
4-(1-Adamantylamino)-2-amino-6-methoxy-5-nitrosopyrimidine
C15H21N5O2
Acta Crystallographica Section C (2001) 57, 2 178-179
a=29.207(2)Å b=6.5860(4)Å c=7.4782(4)Å
α=90° β=90° γ=90°